Trial intelligence / Profile preview

Dexmedetomidine for Postoperative Agitation in Children With Cleft Palate Repair

NCT04928391Phase 3Completed

Sponsor
Assiut University
Start
Jun 2021
Primary completion
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative delirium (POD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Pediatric Anesthesia Emergence Delirium score. Started Jun 2021; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT04928391.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04928391.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call